Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications

By Donath M.   Halban P.  

Diabetologia, Vol. 47, Iss. 3, 2004-03 ,pp. : 581-589

Springer Publishing Company

Access to resources Recommend Favorite

Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes

By Marzo N.   Mora C.   Fabregat M.   Martín J.   Usac E.   Franco C.   Barbacid M.   Gomis R.  

Diabetologia, Vol. 47, Iss. 4, 2004-04 ,pp. : 686-694

Springer Publishing Company

Access to resources Recommend Favorite

A3 Adenosine Receptor: A Plausible Therapeutic Target for Cardio-Protection in Diabetes

By  

Recent Patents on Cardiovascular Drug Discovery, Vol. 7, Iss. 1, 2012-04 ,pp. : 59-70

Bentham Science Publishers

Access to resources Recommend Favorite

A Therapeutic Target for Microvascular Complications in Diabetes: Endothelium- Derived Hyperpolarizing Factor

By  

Current Cardiology Reviews, Vol. 2, Iss. 3, 2006-08 ,pp. : 185-191

Bentham Science Publishers

Access to resources Recommend Favorite

Epoxyeicosatrienoic Acids as a Therapeutic Target for Nephropathy Associated with Diabetes and Hypertension

By  

Current Hypertension Reviews, Vol. 1, Iss. 3, 2005-11 ,pp. : 235-242

Bentham Science Publishers

Access to resources Recommend Favorite